title: Congenital combined pituitary hormone deficiency attributable to a novel PROP1 mutation (467insT).
abstract: Combined pituitary hormone deficiency (CPHD) is an anterior pituitary disorder, commonly resulting in growth retardation. PROP1 gene mutations appear to be frequently responsible for CPHD, particularly in Middle and Eastern Europe and the Americas, but few cases have been reported in Japan.
  
  
  
  Two sisters (aged 8.4 and 4.3 years at presentation) exhibited proportional short stature from about 2 years of age. Genetic analysis determined the nature and location of mutations.
  
  
  
  Pituitary size by magnetic resonance imaging (MRI) indicated only slight hypoplasia, while hormone analysis revealed deficiencies in secretion of growth hormone (GH), thyroid stimulating hormone, prolactin and gonadotropins; adrenocortinotropin secretion appeared adequate. Genetic analysis revealed a novel familial inherited PROP1 mutation. A unique insertion mutation was found in codon 156 (467insT) located in the transcription-activating region of the PROP1 gene. The resulting PROP1 protein (191 amino acids) would lack the transcription activation domain and consequently be non-functional.
  
  
  
  Gene analysis suggested that the siblings had inherited a unique autosomal recessive PROP1 gene mutation resulting in severe GH deficiency and subsequent growth retardation.
authors.affiliation: Dr Nose's Clinic, Osaka, Japan. osamu@nose.or.jp
authors.forename: Osamu
authors.initials: O
authors.lastname: Nose
authors.forename: Keita
authors.initials: K
authors.lastname: Tatsumi
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Nakano
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Amino
mesh_terms: D001483:Base Sequence; D001827:Body Height / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004393:Dwarfism, Pituitary / Q000235:genetics*; D005260:Female; D018398:Homeodomain Proteins / Q000235:genetics*; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D010375:Pedigree; D010907:Pituitary Hormones / Q000172:deficiency* / Q000378:metabolism; D017354:Point Mutation; D011994:Recombinant Proteins / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000627:therapeutic use
chemical_list: D018398:Homeodomain Proteins; D010907:Pituitary Hormones; C102134:Prophet of Pit-1 protein; D011994:Recombinant Proteins; D013963:Thyroid Hormones; D019382:Human Growth Hormone